References
- ChuchalinAGKhaltaevNAntonovNSChronic respiratory diseases and risk factors in 12 regions of the Russian FederationInt J Chron Obstruct Pulmon Dis2014996397425246783
- ArkhipovVArkhipovaDMiravitllesMLazarevAStukalinaECharacteristics of COPD patients according to GOLD classification and clinical phenotypes in the Russian federation: the SUPPORT trialInt J Chron Obstruct Pulmon Dis2017123255326229138554
- KoblizekVMilenkovicBBarczykAPhenotypes of COPD patients with a smoking history in Central and Eastern Europe: the POPE StudyEur Respir J201749160144628495687
- VogelmeierCFCrinerGJMartínezFJGlobal strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summaryArch Bronconeumol20175312814928274597
- WedzichaJCalverleyPAlbertRPrevention of COPD exacerbations: an European Respiratory Society/American Thoracic Society (ERS/ATS) guidelineEur Respir J201750160226528889106
- MiravitllesMVogelmeierCRocheNA review of national guidelines for management of COPD in EuropeEur Respir J20164762563726797035
- Russian Respiratory SocietyChronic obstructive pulmonary diseaseClinical guidelines Available from: http://www.spulmo.ru/obra-zovatelnyeresursy/federalnyeklinicheskierekomendatsiiAccessed August 18, 2017
- Ministry of Health of Russian FederationRequirements for the figuration of clinical recommendations for placement in the Rubricator Available from: http://nasci.ru/_resources/directory/196/common/Pismo_01.09.pdfAccessed August 18, 2017
- MiravitllesMSoler-CataluñaJJCalleMSpanish COPD guidelines (GesEPOC) 2017. Pharmacological treatment of stable chronic obstructive pulmonary diseaseArch Bronconeumol20175332433528477954
- ZykovKAOvcharenkoSIApproaches to drug therapy for COPD in Russia: a proposed therapeutic algorithmInt J Chron Obstruct Pulmon Dis2017121125113328442899
- MiravitllesMAnzuetoAA new two-step algorithm for the treatment of COPDEur Respir J201749160220028179443
- TashkinDPCooperCBThe role of long-acting bronchodilators in the management of stable COPDChest200412524925914718448
- MiravitllesMRiberaAUnderstanding the impact of symptoms on the burden of COPDRespir Res2017186728431503
- GruenbergerJBVietriJKeiningerDLMahlerDAGreater dyspnea is associated with lower health-related quality of life among European patients with COPDInt J Chron Obstruct Pulmon Dis20171293794428360517
- ThomasMHalpinDMiravitllesMWhen is dual bronchodilation indicated in COPD?Int J Chron Obst Pulm Dis20171222912305
- WedzichaJADecramerMFickerJHAnalysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group studyLancet Respir Med2013119920924429126
- WedzichaJABanerjiDChapmanKRIndacaterol–glycopyrronium versus salmeterol–fluticasone for COPDN Engl J Med20163742222223427181606
- 2017 GINA Report, Global Strategy for Asthma Management and Prevention Available from: http://ginasthma.org/2017-gina-report-global-strategy-for-asthma-management-and-prevention/Accessed November 18, 2017
- SinDDMiravitllesMManninoDMWhat is asthma-COPD overlap syndrome (ACOS)? Towards a consensus definition from a roundtable discussionEur Respir J20164866467327338195
- RabeKFCalverleyPMAMartinezFJFabbriLMEffect of roflumilast in patients with severe COPD and a history of hospitalisationEur Respir J201750170015828679611
- CazzolaMRoglianiPCalzettaLHananiaNAMateraMGImpact of mucolytic agents on COPD exacerbations: a pair-wise and network meta-analysisCOPD20171455256328753070
- UzunSDjaminRSKluytmansJAAzithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trialLancet Respir Med2014236136824746000
- BarrechegurenMMonteagudoMFerrerJTreatment patterns in COPD patients newly diagnosed in primary care. A population-based studyRespir Med2016111475326758585
- TariqSMThomasECMaintenance therapy in COPD: time to phase out ICS and switch to the new LAMA/LABA inhalers?Int J Chron Obstruct Pulmon Dis2017121877188228694698
- Calle RubioMAlcázar NavarreteBSorianoJBClinical audit of COPD in outpatient respiratory clinics in Spain: the EPOCONSUL studyInt J Chron Obstruct Pulmon Dis20171241742628182155
- DavisKJLandisSHOhYMContinuing to Confront COPD International Physician Survey: physician knowledge and application of COPD management guidelines in 12 countriesInt J Chron Obstruct Pulmon Dis201410395525565799